Table 4 Clinical outcomes in patients with LVA according to anticoagulant use or not

From: Clinical characteristics and prognostic importance of anticoagulant use in ischemic left ventricular aneurysm: a retrospective cohort study

 

Overall N = 1043

With anticoagulant use N = 322

Without anticoagulant use N = 721

P-value

NACEs

130 (12.5%)

34 (10.6%)

96 (13.3%)

0.225

All-cause mortality

34 (3.3%)

12 (3.7%)

22 (3.1%)

0.574

 Cardiovascular mortality

16 (1.5%)

5 (1.6%)

11 (1.5%)

1.000

Systemic embolism events

75 (7.2%)

10 (3.1%)

65 (9.0%)

<0.001

 Stroke/TIA

62 (5.9%)

7 (2.2%)

55 (7.6%)

<0.001

 Embolization

21 (2.0%)

4 (1.2%)

17 (2.4%)

0.340

Major bleeding events

43 (4.1%)

18 (5.6%)

25 (3.5%)

0.111

  1. All statistical tests were two-sided at a significance level of 0.05.
  2. LVA left ventricular aneurysm, NACEs net adverse clinical events, TIA transient ischemic attack.
Back to article page